Tiedemann Advisors’s Allergan plc AGN Stock Holding History

Tiedemann Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,024	Closed	-$492K	–	474
2017 Q2	$492K	Buy	2,024 +923	+84%	+$217K	0.04%	325
2017 Q1	$263K	Buy	+1,101	New	+$256K	0.02%	331

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Tiedemann Advisors's AGN Position: Q3 2017 in Review

Tiedemann Advisors sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 2,024 shares — an estimated $492K sold.

Tiedemann Advisors first reported a position in AGN in Q1 2017 and held it in 2 quarters. The position peaked at $492K in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

Tiedemann Advisors reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
Tiedemann Advisors sold 2,024 Allergan plc shares in Q3 2017, an estimated $492K.
Tiedemann Advisors first reported a position in Allergan plc in Q1 2017 and held it in 2 quarters.
Tiedemann Advisors's Allergan plc position peaked at $492K in Q2 2017.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Tiedemann Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.